CVS Health Corp vs Warner Music Group Corp — how do they compare? CVS Health Corp trades at $86.16 (market cap $112.29B), while Warner Music Group Corp trades at $28.72 (market cap $15.12B). The key difference: CVS Health Corp is far larger — about 7.4× Warner Music Group Corp's market cap, and CVS Health Corp pays the higher dividend (3.03%). Which is the better fit depends on your goals — on Pluang, investors hold CVS Health Corp for 83 Days and Warner Music Group Corp for 96 Days on average.
| CVS | WMG | |
|---|---|---|
Market Cap | $112.29B | $15.12B |
Volume | 7,763,676 | 2,966,414 |
Sector | Health | Media |
52-Week High | $110.60 | $34.72 |
52-Week Low | $70.08 | $23.65 |
Typical Hold Time | 83 Days | 96 Days |
Enterprise Value | $174.64B | $19.42B |
Dividend Yield | 3.03% | 2.77% |
Signals from Pluang's Aura AI — not financial advice
CVS Health trades at $87.80, down 0.17% with a bearish technical signal. The company shows strong revenue growth to $402.1B in 2025 and has beaten earnings estimates for three consecutive quarters. Analyst consensus is overwhelmingly bullish with 85% buy ratings and a $111.20 price target representing 27% upside. Recent news highlights Aetna's 2027 Medicare plan enhancements and quarterly dividend declarations.
CVS presents a compelling value opportunity with attractive valuation metrics (P/E 23.17, P/S 0.27) and strong analyst support. Key risks include reimbursement pressure, regulatory scrutiny from ongoing investigations, and declining net margins. The stock's current technical weakness contrasts with solid fundamentals and positive earnings momentum.
Warner Music Group (WMG) trades at $28.91, up 2.66% with strong technical momentum and bullish moving average signals. The company reported solid Q2 2026 earnings, beating EPS estimates with $0.38 vs. $0.34 expected, while revenue growth continues with 2026 projections showing $7.3B. Recent AI partnerships with Suno and NetEase Cloud Music highlight strategic positioning in the evolving music industry landscape.
WMG presents a compelling investment case with 66.7% analyst buy ratings and a $39.50 consensus price target representing 36.6% upside. However, risks include recent CFO departure, ongoing AI copyright litigation, and margin pressure from 2025's 5.44% net margin. The stock's premium valuation at 23.12 P/E requires continued execution on streaming growth and AI initiatives.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.
Read more on CVS →Warner Music Group is the third largest of the three major global record labels, with Vivendi's Universal Music in first and Sony Music in second. Warner's larger segment, recorded music, consists of iconic labels like Atlantic Records, Warner Records, and Parlophone Records and popular artists such as Ed Sheeran, Cardi B, Dua Lipa, and Blake Shelton. Warner Chappell, the firm's publishing arm, is the home to over 65,000 composers and songwriters with over a million copyrights represented. Warner is controlled by Access Industries, which owns an 84% economic interest and 99% of voting rights.
Read more on WMG →